Search in:

OncoImmunology Volume 2, 2013 - Issue 9

Submit an article Journal homepage

Open access

743

Views

CrossRef citations to date

Altmetric

Author's View

Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients

Karthick Raja Muthu Raja Babak Myeloma Group; Department of Pathological Physiology; Faculty of Medicine; Masaryk University; Brno, Czech RepublicCorrespondence[email protected]

Roman Hajek Babak Myeloma Group; Department of Pathological Physiology; Faculty of Medicine; Masaryk University; Brno, Czech Republic; Department of Clinical Hematology; University Hospital of Brno; Brno, Czech Republic; Department of Hemato-oncology; University Hospital of Ostrava; Ostrava, Czech Republic

Article: e25619 | Received 27 Jun 2013, Accepted 02 Jul 2013, Published online: 09 Jul 2013

Cite this article
https://doi.org/10.4161/onci.25619

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (9)

Douglas E. Joshua, Slavica Vuckovic, James Favaloro, Ka Hei Aleks Lau, Shihong Yang, Christian E. Bryant, John Gibson & Phoebe Joy Ho. (2021) Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma. Frontiers in Immunology 12.
Crossref

Jinheng Wang, Yongjiang Zheng, Chenggong Tu, Hui Zhang, Karin Vanderkerken, Eline Menu & Jinbao Liu. (2020) Identification of the immune checkpoint signature of multiple myeloma using mass cytometry‐based single‐cell analysis. Clinical & Translational Immunology 9:5.
Crossref

Felix Marsh-Wakefield, Annabel Kruzins, Helen M. McGuire, Shihong Yang, Christian Bryant, Barbara Fazekas de St. Groth, Najah Nassif, Scott N. Byrne, John Gibson, Christina Brown, Stephen Larsen, Derek McCulloch, Richard Boyle, Georgina Clark, Douglas Joshua, Phoebe Joy Ho & Slavica Vuckovic. (2019) Mass Cytometry Discovers Two Discrete Subsets of CD39−Treg Which Discriminate MGUS From Multiple Myeloma. Frontiers in Immunology 10.
Crossref

Laurens E. Franssen, Inger S. Nijhof, Chad C. Bjorklund, Hsiling Chiu, Ruud Doorn, Jeroen van Velzen, Maarten Emmelot, Berris van Kessel, Mark-David Levin, Gerard M.J. Bos, Annemiek Broijl, Saskia K. Klein, Harry R. Koene, Andries C. Bloem, Aart Beeker, Laura M. Faber, Ellen van der Spek, Reinier Raymakers, Pieter Sonneveld, Sonja Zweegman, Henk M. Lokhorst, Anjan Thakurta, Xiaozhong Qian, Tuna Mutis & Niels W.C.J. van de Donk. (2018) Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients. Oncotarget 9:74, pages 34009-34021.
Crossref

Deniz Ekinci & Aysun Özkan. (2017) Multipl miyelom’da CD4+ regülatör T hücrelerin rolü. Cukurova Medical Journal (Çukurova Üniversitesi Tıp Fakültesi Dergisi) 42:3, pages 546-551.
Crossref

Zhiwei Ji, Jing Su, Dan Wu, Huiming Peng, Weiling Zhao, Brian Nlong Zhao & Xiaobo Zhou. (2016) Predicting the impact of combined therapies on myeloma cell growth using a hybrid multi-scale agent-based model. Oncotarget 8:5, pages 7647-7665.
Crossref

Fanny Pojero, Alessandra Casuccio, Caterina Giambanco, Matteo Bulati, Silvio Buffa, Francesco Di Bassiano, Francesco Gervasi, Calogero Caruso & Giuseppina Colonna Romano. (2016) Bone marrow B lymphocytes in multiple myeloma and MGUS: Focus on distribution of naïve cells and memory subsets. Leukemia Research 49, pages 51-59.
Crossref

Oliver Kepp, Michaela Semeraro, José Manuel Bravo-San Pedro, Norma Bloy, Aitziber Buqué, Xing Huang, Heng Zhou, Laura Senovilla, Guido Kroemer & Lorenzo Galluzzi. (2015) eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars in Cancer Biology 33, pages 86-92.
Crossref

Evangelos Terpos, Nikolaos Kanellias & Krzysztof Giannopoulos. (2014) Biology and management of myeloma-related bone disease. Acta Haematologica Polonica 45:2, pages 107-121.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients

Articles from other publishers (9)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients

Citations (9)

Articles from other publishers (9)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date